Istanbul Medipol University
Beykoz, Istanbul, 34810, Turkey (Türkiye)
NCT Number: NCT06506383
This study aims to analyze the geographical variations and identify key environmental and behavioral predictors of coronary artery disease (CAD) mortality in Turkiye.
Looking for future studies?
Notify MeAll sexes
Observational
Beykoz, Istanbul, 34810, Turkey (Türkiye)
A 10-year longitudinal province-level data was used to identify change trajectories of CAD mortality. . Environmental determinants (such as air quality and climatic conditions) and behavioral factors of alcohol consumption and smoking were examined for their association with CAD mortality change trajectories using Ordinal Logistic Regression models.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No Intervention as this is an ecological study
Time frame: 2010-2019
coronary artery disease (CAD) mortality per 100,000 population
Medipol University
Other
Geographical Variations and Predictors of Coronary Artery Disease Mortality in Turkiye: An Environmental and Behavioral Analysis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05406284
Arterial Occlusive Diseases, Arteriosclerosis
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07248202
Arterial Occlusive Diseases, Arteriosclerosis
Cairo, Egypt
View Trial DetailsNCT07148518
Arterial Occlusive Diseases, Arteriosclerosis
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial Details